Skip to main content
AAWH logo

AAWH · Ascend Wellness Holdings, Inc.

$0.40 +0.00 (+0.00%) At close · Jul 30
Market Cap
$81.19M
Shares
202.97M

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$500.58M -10.9%
FY2025 Revenue FY2019–FY2025
Net Income
-$118.19M -39.1%
FY2025 Net Income FY2019–FY2025
Gross Margin
33.9% +1.1pp
FY2025 Gross Margin FY2019–FY2025
Operating Margin
-3.4% -4.2pp
FY2025 Operating Margin FY2019–FY2025
Diluted EPS
-$0.58 -45%
FY2025 Diluted EPS FY2019–FY2025
Operating Cash Flow
$38.05M -48.1%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
$489.52M $500.58M $561.6M $518.59M $405.93M $332.38M $143.73M $12.03M
$314.52M $330.9M $377.39M $363.47M $271.36M $196.41M $82.82M $8.74M
$175M $169.68M $184.21M $155.12M $134.56M $135.97M $60.91M $3.29M
33.9% 32.8% 29.91% 33.15% 40.91% 42.38% 27.33%
$174.95M $169.69M $179.48M $158.74M $137.09M $116.67M $53.07M $29.41M
$30.35M $30.16M $27.1M $23.59M $9.82M $6.75M $7.53M $2.07M
$73.41M $73.53M $66.16M $58.98M $37.11M $22.22M $12.56M $4.1M
$186.69M $179.48M $158.74M $142.09M $153.18M $53.07M $29.41M
-$16.95M -$17.01M $4.73M -$3.62M -$7.53M -$17.2M $7.85M -$26.12M
-3.4% 0.84% -0.7% -1.85% -5.18% 5.46% -217.1%
$56.46M $56.52M $70.89M $55.36M $29.58M $5.02M $20.41M -$22.02M
$60.36M $51.29M $45.26M $36.98M $32.44M $63.99M $12.99M $6.48M
-$59.22M -$49.8M -$44.56M -$11.14M -$31.68M -$63.73M -$12.99M -$6.45M
-$76.17M -$66.82M -$39.82M -$14.76M -$39.21M -$80.94M -$5.14M -$32.58M
$52.25M $51.38M $45.17M $33.45M $41.69M $41.72M $18.7M $667K
-$128.43M -$118.19M -$84.99M -$48.21M -$80.9M -$122.66M -$25.44M -$31.9M
-23.61% -15.13% -9.3% -19.93% -36.9% -17.7% -265.08%
$0 $0 $1.6M -$1.35M
USD/shares -$0.58 -$0.40 -$0.24 -$0.44 -$0.82 -$0.27 -$0.37
USD/shares -$0.58 -$0.40 -$0.24 -$0.44 -$0.82 -$0.27 -$0.37
shares 203.48M 212.43M 199.15M 183.38M 149.43M 95.17M 87.29M
shares 203.48M 212.43M 199.15M 183.38M 149.43M 95.17M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
0.66×
Peer median 1.03×
EV/EBIT
P/E (TTM)
Peer median 12.63×

Peer medians compare against the 41 similar-size Drug Manufacturers - Specialty & Generic companies (of 91 listed).

Valuation over time computed as of each quarter's filing date

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Product & Service (USD)

Component FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Retail $339,563,000 $372,237,000 $371,172,000 $305,935,000 $231,930,000 $103,859,000 $11,204,000
Third Party Wholesale $161,018,000 $189,362,000 $147,418,000 $99,991,000
Wholesale $148,483,000 $57,452,000 $1,970,000
Key facts CIK 1756390 CUSIP 04351N106 Visit website Investor relations